Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Its triple GIP/GLP-1/glucagon agonist mechanism produced the most striking weight-loss numbers ever reported in a Phase 2 trial of an injectable peptide, and its broad TRIUMPH Phase 3 program is poised to expand understanding of how triple receptor modulation affects obesity, diabetes, liver disease, cardiovascular risk, sleep apnea, and musculoskeletal health
It has not received FDA approval for therapeutic use in humans
Its diverse areas of investigation have made it one of the most recognized peptides in laboratory research
Step-by-Step Reconstitution and Storage Guidance Reconstituted peptide solutions should be stored at 28C, protected from light, never frozen, and discarded if cloudy or discoloured
Low Levels of Serum Total Vitamin B12 Are Associated with Worse Metabolic Phenotype in a Large Population of Children, Adolescents and Young Adults, from Underweight to Severe Obesity
US$ 25.72
US$ 23.56
US$ 29.73
US$ 29.31
